Ignite Creation Date:
2024-10-26 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06502483
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-09
Brief Title:
PRISM for Depression and Anxiety in Young Adults with Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Treatment Development Study of the Promoting Resilience in Stress Management PRISM Intervention for Depression and Anxiety in Young Adults with Cancer
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRISM
Brief Summary:
This research study is being done to test the feasibility of an existing supportive program PRISM to address psychological symptoms ie depressive and anxiety symptoms that young adult participants diagnosed with cancer may experience
The name of the intervention used in this research study is
-Promoting Resilience in Stress Management PRISM Program
The name of the intervention used in this research study is
-Promoting Resilience in Stress Management PRISM Program
Detailed Description:
This research study is being done to test the initial feasibility and acceptability of a six-session skills-based resilience coaching intervention Promoting Resilience in Stress Management PRISM Rosenberg et al 2018 Rosenberg et al 2021 that targets four resilience resources stress management goal setting cognitive reframing and meaning-making for young adult patients 18-25 years old with nonmetastatic cancer who report moderate depressive andor anxiety symptoms
The research study procedures include screening for eligibility completing one diagnostic assessment of depressive and anxiety symptoms pre-intervention and post-intervention questionnaires completion of the six-session PRISM intervention and a semi-structured exit interview about the experience with the PRISM intervention
Participation in this research study is expected to last approximately 2 to 3 months
It is expected that up to 15 young adults with cancer ie participants and up to a total of 15 support persons ie friends or family members who participants will have an option to invite for the final session of the intervention will take part in this research study
The Hans and Mavis Lopater Foundation is funding this research study by providing philanthropic support
The research study procedures include screening for eligibility completing one diagnostic assessment of depressive and anxiety symptoms pre-intervention and post-intervention questionnaires completion of the six-session PRISM intervention and a semi-structured exit interview about the experience with the PRISM intervention
Participation in this research study is expected to last approximately 2 to 3 months
It is expected that up to 15 young adults with cancer ie participants and up to a total of 15 support persons ie friends or family members who participants will have an option to invite for the final session of the intervention will take part in this research study
The Hans and Mavis Lopater Foundation is funding this research study by providing philanthropic support
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None